Oxidative stress is an important determinant not only in the pathogenesis of Alzheimer's disease (AD), but also in insulin resistance (InsRes) and diabetic complications. Forkhead box class O (FoxO) transcription factors are involved in both insulin action and the cellular response to oxidative stress, thereby providing a potential integrative link between AD and InsRes. For example, the expression of intra-and extracellular antioxidant enzymes, such as manganese-superoxide dismutase and selenoprotein P, is regulated by FoxO proteins, as is the expression of important hepatic enzymes of gluconeogenesis. Here, we review the molecular mechanisms involved in the pathogenesis of AD and InsRes and discuss the function of FoxO proteins in these processes. Both InsRes and oxidative stress may promote the transcriptional activity of FoxO proteins, resulting in hyperglycaemia and a further increased production of reactive oxygen species (ROS). The consecutive activation of c-Jun N-terminal kinases and inhibition of Wingless (Wnt) signalling may result in the formation of b-amyloid plaques and s protein phosphorylation. Wnt inhibition may also result in a sustained activation of FoxO proteins with induction of apoptosis and neuronal loss, thereby completing a vicious circle from oxidative stress, InsRes and hyperglycaemia back to the formation of ROS and consecutive neurodegeneration. In view of their central function in this model, FoxO proteins may provide a potential molecular target for the treatment of both InsRes and AD.
Introduction
Epidemiological studies have shown an increased risk for dementia, including Alzheimer's disease (AD) in diabetes mellitus and vice versa, 1,2 therefore, suggesting common pathophysiological mechanisms. 3 Oxidative stress is considered not only as a major factor in the pathogenesis of AD, but it is also an important determinant in the development of insulin resistance (InsRes) and diabetic complications, 4, 5 thus suggesting common pathophysiological mechanisms. 3 Forkhead box class O (FoxO) transcription factors are important intracellular regulators of diverse metabolic processes such as hepatic glucose production and the cellular response to oxidative stress at the transcriptional level. 6 Here, we review the potential integrative function of FoxO proteins in the pathogenesis of both AD and InsRes in the context of oxidative stress.
Alzheimer's disease

Structural changes in AD
The main histological finding in AD is the accumulation of extracellular senile plaques consisting mainly of b amyloid (Ab). 7, 8 Ab is derived from amyloid precursor protein through cleavage. Amyloid precursor protein processing through the so-called amyloidogenic pathway b requires two secretases, b and g, that subsequently cleave amyloid precursor protein leading to the formation of non-soluble, deleterious Ab. It has been shown that accumulation of Ab damages synaptic functions and results in neurodegeneration through induction of apoptosis. 9 The intracellular accumulation of neurofibrillary tangles (NFT) is a further pathohistological feature of AD. NFT consist of neurofilament proteins and an abnormally phosphorylated form of t protein. 10 Hyperphosphorylation of t protein results in neuronal degeneration through deleterious effects on axonal transport mechanisms and cell shape. 11, 12 Several kinases are able to phosphorylate t protein, for example cyclin-dependent kinase 5, casein kinase 1 and glycogen synthase kinase 3 (GSK-3) b. 13 Interestingly, the cyclin-dependent kinase 5 pathway is interlinked with GSK-3 b activation, as the cyclin-dependent kinase 5 activator p35 and its breakdown product p25 can increase the activity of GSK-3 b.
14,15
Oxidative stress in the pathogenesis of AD Accumulation of oxidative damage and the activation of diverse signalling pathways by oxidative stress in brain tissue are associated with AD ( Figure 1 ). 16, 17 In a Drosophila model of AD, oxidative stress was established to be causative in neurodegeneration. 18 More interestingly, this was due to increased signalling through c-Jun N-terminal kinases (JNK), a pathway that is also related to oxidative stress and InsRes. 19 JNK activation through hydrogen peroxide results in the activation of g secretase, which, as discussed above, is important in Ab-plaque formation. 20 In addition, the early steps in Ab-plaque formation are associated with the generation of hydrogen peroxide, thus contributing to a vicious circle in this process. 21 In brains from patients with AD, the expression of enzymes catalyzing the generation of reactive nitrogen and oxygen species, such as nitric oxide synthases 1-3 and NADPH oxidases 1 and 3, was found to be increased. 22 In the same study, a reduced expression of genes associated with cellular protection from oxidation, such as uncoupling protein and PPAR a and d, was described. Other metabolic changes in human brains from patients with AD include increased lipid peroxidation. 23 Lipid peroxidation results in the accumulation of 4-hydroxynonenal, a reactive aldehyde and potent neurotoxin. 24 4-Hydroxynonenal promotes the aggregation of Ab peptides and accelerates the formation of deleterious Ab fibrils. 25 Furthermore, DJ-1, a protein potentially associated with degenerative tauopathies, was found to be irreversibly oxidized in brains of patients with AD. 26 
FoxO proteins
Family of FoxO proteins FoxO proteins form a family of nuclear transcription factors, with a highly conserved DNA-binding domain of about 100 amino acids as the common structural feature of this class of proteins. This DNAbinding domain has a so-called 'winged helix' or forkhead box motif, and classification of forkhead proteins is based on their homology within this region. 27, 28 FoxO proteins are different from other forkhead-type transcription factors in terms of their DNA-binding motif: It contains an insert of five amino acids, which enables them to interact specifically with distinct targets within the genome through a so-called insulin responsive element [(C/G)(A/T) AAA(C/A)(A)]. 29 Four different FoxO proteins have been characterized in mammals-FoxO1a, FoxO3a, FoxO4 and FoxO6. They are phosphorylated by protein kinase B (PKB or Akt) at a conserved C-terminal phosphorylation motif, resulting in their nuclear exclusion and the termination of FoxO transcriptional activity. 30 The most recently discovered protein FoxO6 represents an exception in that it lacks the phosphorylation motif and is, therefore, not controlled by nuclear exclusion. FoxO proteins are expressed in several tissues, including the brain, liver, pancreatic b cells and adipose tissue. 6, 31 So far, FoxO6 has been characterized in developing and mature cells of the central nervous system of mice.
32,33
Regulation of FoxO proteins The functions of FoxO proteins are tightly controlled by clustered phosphorylation, acetylation and ubiquitinylation. For example, the serine/threonine kinase PKB inhibits FoxO by phosphorylating three highly conserved aminoacyl residues, Thr24, Ser256 and Ser319 (numbers refer to the FoxO1a isoform). Ser256 seems to act as a 'gatekeeper', meaning that phosphorylation of Ser256 is necessary for the subsequent phosphorylation of Thr24 and Ser319. Subsequently, other kinases such as the serum-and glucocorticoid inducible kinase, the dual-specificity tyrosine-phosphorylation-regulated kinase 1 and casein kinase 1 phosphorylate specific serine residues. This clustered phosphorylation results in the formation of a nuclear export protein complex with Ran and Crm-1 and eventually to nuclear exclusion through enhanced 14-3-3 binding. [34] [35] [36] Once in the cytoplasm, FoxO proteins can be targeted for ubiquitinylation and proteosomal degradation by Skp2. 37, 38 For a comprehensive review on phosphorylation/ acetylation sites and proteins that interact with FoxO proteins see Ref. 6 .
Physiological functions of FoxO proteins
FoxO proteins are implicated in the regulation of cellular proliferation and differentiation, cell survival and apoptosis and, therefore, in the development of proliferative diseases and age-related changes. FoxO functions have been reviewed in detail elsewhere. 6, 31, 39, 40 Here, we will briefly depict their function in the development of InsRes and then focus on the FoxO response to oxidative stress.
FoxO proteins and InsRes. InsRes is characterized by a decreased sensitivity towards the effects of insulin in tissues such as muscle, adipose tissue and the liver. Resistance can be mediated on several levels, including the insulin receptor and downstream signalling. 41 In the liver, FoxO1 is the main transactivator controlling the expression of two important gluconeogenic enzymes, phosphoenol-pyruvate carboxy-kinase and the glucose-6-phosphatase catalytic subunit. In the absence of insulin, FoxO1 is located in the nucleus and promotes transcription and thus hepatic glucose production. Insulin activates PKB through phosphoinositide 3 0 -kinase, resulting in phosphorylation and nuclear exclusion of FoxO as described above. 42 InsRes results in the impairment of the phosphoinositide 3 0 -kinase/PKB pathway and of PKB-mediated inhibition of FoxO phosphorylation and subsequent inactivation. Increased hepatic FoxO activity may result and enhance the transcription of gluconeogenic enzymes and finally hepatic glucose production. In a vicious circle, sustained FoxO activity may promote hyperglycaemia and consequences thereof, including secondary oxidative stress.
FoxO proteins and oxidative stress. Oxidative stress results from a potentially harmful dysbalance between steady-state concentrations of oxidants and antioxidants in favour of the oxidizing species, which may be the consequence of an excessive generation of reactive oxygen species (ROS). ROS are by-products of basic aerobic metabolism and, although potentially deleterious, are linked to the activation of various cellular signalling cascades, including receptor tyrosine kinase-dependent signalling and the phosphoinositide 3 0 -kinase/PKB pathway. [43] [44] [45] Furthermore, formation of ROS, the accumulation of oxidative damage and even ROS-induced signalling processes are proposed to be a result of and to contribute to several diseases, conditions and phenomena, including ageing, cancer, atherosclerosis and cardiovascular disease as well as InsRes and AD. 46 FoxO proteins are associated with the cellular response to oxidative stress. Expression of the intracellular antioxidant enzymes, manganese-superoxide dismutase and catalase, is regulated by FoxO proteins. 47, 48 Recently, it has been found that FoxO1a induces the expression of selenoprotein P in liver cells, a secretory protein with antioxidant properties. 49, 50 The mechanism by which oxidative stress induces the upregulation of FoxO-controlled genes involves the Wingless (Wnt) proteins and b-catenin pathway. Briefly, Wnt proteins inactivate GSK-3 b after binding to a complex of lipoprotein receptorrelated proteins 5/6 and frizzled proteins in the cytoplasm. 51 Inactivation of GSK-3 terminates the degradation of cytoplasmatic b-catenin, which then accumulates and eventually translocates to the nucleus. In the nucleus, it modulates gene expression by interaction with transcription factors, including the T-cell factor family of transcription factors. Interestingly, this so-called canonical Wnt pathway controls genes in glucose and lipid metabolism that exert functions opposed to those of FoxO-controlled genes 39 ( Figure 2 , panel a). ROS inhibit Wnt proteins and the canonical Wnt pathway by diverting b catenin from T-cell factor to FoxO. 52 This results in the accumulation and binding of b-catenin to FoxO as a cofactor, thus increasing FoxO transcriptional activity in the nucleus. 53, 54 Although the increased expression of antioxidant enzymes is meant to address the accumulation of ROS, a sustained activation of FoxOs, such as in the case of persistent oxidative stress, may foster the initiation of cellular apoptosis. FoxO proteins are involved in this process; for example it has been shown that FoxO3a stimulates the expression of proapoptotic genes such as those of Fas ligand or BIM, a member of the BCL-2 family. [55] [56] [57] Further, FoxO proteins induce cell-cycle arrest by stimulating production of the cyclin-dependent kinase inhibitor p27 Kip1 and repressing the expression of the cyclins D1 and D2. 58, 59 The FoxO response to oxidative stress is illustrated in Figure 2 (panel b) .
In summary, the FoxO response to oxidative stress is twofold. Short-term activation results in the upregulation of protective mechanisms. However, failure to cope with oxidative stress and an associated sustained FoxO activation may result in the induction of apoptosis. This twofold action has been shown, for example for pancreatic b cells, in which FoxO1 not only protects from oxidative stress-associated failure, 60 but may also induces apoptosis.
61
Linking AD and InsRes: the FoxO response to oxidative stress
Oxidative stress is a common feature in the pathophysiology of InsRes and AD. Moreover, FoxO proteins have a pivotal function in the regulation of glucose and energy homeostasis in insulin-sensitive tissues as well as in oxidative stress control and apoptosis. Therefore, it is tempting to regard the FoxO family of proteins as an integrating factor in the development of both diseases. Oxidative stress triggers FoxO activation, for example through inhibition of Wnt and increased b-catenin co-binding, as described before, to upregulate the transcription of antioxidant enzymes. Interestingly, the products of FoxO target genes, selenoprotein P and manganese-superoxide dismutase, are known protective proteins in the brain. This is consistent with the finding that selenoprotein P is co-localized with Ab plaques and NFTs, 62 although the functional relevance thereof is yet unknown, and that manganese-superoxide dismutase activity is increased in neurons under oxidative stress. 63 However, inhibition of Wnt results in the activation of GSK-3 because of the abolition of dishevelled (dvl)-mediated inhibition. 64 Furthermore, the inhibition of both isoforms of GSK-3 has been shown to be neuroprotective in vitro. 65 Increased local levels of GSK-3 are associated with neuronal dystrophy and NFT as detected by immunohistochemistry. 66, 67 Increased GSK-3 activity is connected to increased t protein phosphorylation 68 and promotes Ab synthesis 69 and neuronal apoptosis. 70 As discussed above, sustained activation of FoxO may render a system prone to apoptosis rather than to support the system's antioxidant capacity. Ab induced phosphorylation and inactivation of FoxO in a p66Shc-dependent manner 71 and FoxO proteins are directly involved in neuronal loss through an MST1-dependent pathway. 72 The FoxO response to oxidative stress integrates the above with the InsRes syndrome. Oxidative stress promotes the development of InsRes by activation of JNK that results in the attenuation of intracellular insulin-signal transduction.
19 JNK activation has also been shown to be an important player in AD pathogenesis by promoting t phosphorylation at Thr205 and Ser422, and Ab-induced Fas ligand-dependent neuronal apoptosis. [73] [74] [75] Interestingly, JNK directly influences FoxO activity in hepatic cells, 76 and FoxO activation is associated with increased JNK activity in human beings. 77 Sustained activation of FoxO proteins with consecutively increased transcription of gluconeogenic enzymes in the liver leads to hyperglycaemia and subsequent hyperinsulinaemia-both detrimental in the pathophysiology of AD. 78, 79 Interestingly, it has been shown that hyperinsulinaemia coincides with Ab accumulation in mice lacking insulin-degrading enzyme, a protease involved in the clearance of both insulin and Ab. 80 Prolonged hyperglycaemia leads to the formation of advanced glycation end products. Advanced glycation end products can activate distinct receptors, resulting in further intracellular ROS formation. 4 In this way, a vicious circle from oxidative stress- through InsRes and hyperglycaemia back to oxidative stress-is established, thereby promoting sustained FoxO activity and induction of apoptosis. 81 This pathophysiological sequence is summarized in Figure 3 .
New directions and future approaches
Oxidative stress and the subsequent cellular response to ROS present a common pathway in the molecular pathogenesis of AD and InsRes. FoxO proteins are important transcription factors that regulate glucose homeostasis, tissue metabolism, the oxidative stress response and apoptosis-all of which are factors that are intertwined in the pathogenesis of AD and InsRes. Oxidative stress-mediated JNK activation and decreased Wnt signalling with subsequent GSK-3 activation are important factors in the development of AD. Both are connected to the FoxO response, which is pivotal in the upregulation of cellular antioxidative pathways and eventually apoptosis. At the same time, upregulation of FoxO transcriptional activity results in hyperglycaemia, another factor potentially contributing to the pathophysiology of AD.
Future approaches will focus on further transcription factors activated by oxidative stress and involved in the pathogenesis of AD and InsRes and its complications. For instance, the transcription factor NFkB has been implicated both in neuronal apoptosis as well as in diabetes mellitus because of oxidative stress. 82 Given the depicted integrative function in cellular stress resistance, FoxO proteins provide an ideal target for therapies that aim towards the origin rather than the symptoms of both disease states. Promising prospects in favour of this future perspective derive from the fact that agents with both antidiabetic and antioxidant properties, such as thiazolidinediones, exert positive effects both on InsRes and AD neuropathology. 
